Yu Zheng

Title: Yu Zheng - Innovator in Synthetic Antibody Mimic Peptides

Introduction

Yu Zheng is a prominent inventor based in Stockton, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of synthetic antibody mimic peptides. His innovative work has the potential to impact various therapeutic applications.

Latest Patents

Yu Zheng holds a patent for synthetic antibody mimic peptides. This patent relates to compositions and methods that comprise peptide molecules mimicking the binding and functional properties of native antibodies. The patent includes peptide-drug conjugates (PDCs) that utilize these mimic peptides. The targets of these peptides include important receptors such as epidermal growth factor receptor (EGFR), human epidermal growth factor receptor 2 (HER2), vascular endothelial growth factor (VEGF), programmed cell death protein 1 (PD-1), and programmed death-ligand 1 (PD-L1). The disclosure also involves the application of the knob-socket computational model to design antibody mimics for proteins.

Career Highlights

Yu Zheng is currently associated with Formurex, Inc., where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and excellence in the field of biotechnology.

Collaborations

Yu Zheng collaborates with notable colleagues, including Xiaoling Li and Jerry Tsai. Their combined expertise contributes to the success of their projects and the advancement of their research.

Conclusion

Yu Zheng is a key figure in the development of synthetic antibody mimic peptides, with a focus on innovative solutions for therapeutic applications. His contributions to the field are noteworthy and continue to pave the way for future advancements.